3 Things You Should Expect in Pfizer's Q4 Earnings Update [The Motley Fool]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: The Motley Fool
3 Things You Should Expect in Pfizer's Q4 Earnings Update Pfizer ( NYSE:PFE reported third-quarter results Another quarterly update is just around the corner. On Tuesday, Jan. 9, Pfizer will announce its fourth-quarter and full-year 08 results. Here are three things you should expect in the pharma company's Q update. Image source: Getty Images. . Mixed results for key blockbusters Pfizer currently has 0 On the positive side, sales for cancer drug Ibrance will almost certainly continue to increase on a year-over-year basis, thanks to uptake in international markets. Anticoagulant Eliquis, which Pfizer co-markets with Bristol-Myers Squibb There's a good chance that smoking-cessation product Chantix and longtime mainstays Lipitor and Norvasc will also keep up their momentum. The latter two drugs are well past their prime in the U.S. and Europe, but are enjoying solid sales growth in China. What about the negatives? Although Pfizer won a six-month extension on U.S. patent exclusivity for
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder [MSNBC.com]MSNBC.com
- Want $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks [Yahoo! Finance]Yahoo! Finance
- Pfizer's First Gene Therapy Gets Approval for Clotting Disorder [BNN Bloomberg (Canada)]BNN Bloomberg
- UPDATE 2-US FDA approves Pfizer's gene therapy for rare bleeding disorder [Yahoo! Finance]Yahoo! Finance
- Antibody-Drug Conjugates (ADC) Industry Overview 2024: Market to Exceed $40 Billion by 2029, Driven by Daiichi Sankyo's Enhertu, Roche's Kadcyla, Astellas Pharma, Pfizer's Padcev, & Gilead's Trodelvy [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- 4/16/24 - Form PX14A6G
- PFE's page on the SEC website